Pnc Financial Services Group, Inc. Cue Biopharma, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding CUE
# of Institutions
50Shares Held
17.5MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY6.82MShares$4.5 Million1.47% of portfolio
-
Catalytic Wealth Ria, LLC Cambridge, MA3.33MShares$2.2 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.04MShares$2.01 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA801KShares$528,5060.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$499,4450.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $23.4M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...